Interestingly, SLC25A6 was downregulated in several cancer cell lines upon treatment with camptothecin, including the leukemia cell lines HL-60 and K562, suggesting that reduced levels of SLC25A6 may aid in conferring resistance to camptothecin-induced apoptosis [37]. This evidence concerns the gene SLC25A6 and cancer.